Literature DB >> 20476942

Chemokines and chemokine receptors in inflammation of the CNS.

Andrzej Glabinski1, Marcin Jalosinski, Richard M Ransohoff.   

Abstract

Chemokines are small chemotactic cytokines involved in numerous biologic and pathologic processes. They are important mediators of leukocyte trafficking, development of inflammation, tumor metastasis and immune cell differentiation. Inflammation in the CNS develops in a unique manner that is partially due to the existence of the blood-brain barrier. All inflammatory cells migrate to the CNS through the blood-brain barrier in a multistep process of cell-cell interactions. The key players involved in this transmigration are adhesion molecules and chemokines. Substantial knowledge about involvement of chemokines and their receptors in the immune-mediated CNS inflammation has been accumulated in recent years. Initially, these studies involved animal models of neuroinflammation, however, later studies on human diseases were performed. Results obtained in these experiments confirmed the significant role of the chemokine system in certain pathologies. These observations suggest that antichemokine strategies may be beneficial in the treatment of immune-mediated CNS inflammation.

Entities:  

Year:  2005        PMID: 20476942     DOI: 10.1586/1744666X.1.2.293

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  2 in total

1.  Altered Expression of CXCL13 and CXCR5 in Intractable Temporal Lobe Epilepsy Patients and Pilocarpine-Induced Epileptic Rats.

Authors:  Ruohan Li; Limin Ma; Hao Huang; Shu Ou; Jinxian Yuan; Tao Xu; Xinyuan Yu; Xi Liu; Juan Yang; Yangmei Chen; Xi Peng
Journal:  Neurochem Res       Date:  2016-11-21       Impact factor: 3.996

2.  Distinct Gene Profiles of Bone Marrow-Derived Macrophages and Microglia During Neurotropic Coronavirus-Induced Demyelination.

Authors:  Carine Savarin; Ranjan Dutta; Cornelia C Bergmann
Journal:  Front Immunol       Date:  2018-06-11       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.